Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortInjection for relapsing MS with no flu-like effects.Injectable disease-modifying therapy for relapsing multiple sclerosis.
Body systemBrain & NervesBrain & Nerves
Drug classMultiple sclerosis therapiesMultiple sclerosis therapies
SupplyPrescription onlyPrescription only
Main usesRelapsing MS, Clinically isolated syndromeRelapsing MS, Clinically isolated syndrome
How it worksDiverts the immune system away from attacking nerve coverings.Calms the immune attacks on nerve coverings.
Starts workingMonths for benefitMonths for benefit
Half-lifeNot applicableHours (effect lasts longer)
Typical adult dose20 mg daily or 40 mg three times a week by subcutaneous injection.Depends on the product: 30 micrograms IM weekly, 22–44 micrograms SC three times a week, or 250 micrograms SC every other day.
FormsSubcutaneous injectionSubcutaneous injection, Intramuscular injection
Common side effectsInjection site reactions, Flushing, Chest tightness after injection, AnxietyFlu-like symptoms, Injection site reactions, Headache, Muscle aches
Serious side effectsLipoatrophy at injection sites, Immediate post-injection reaction, Liver injury (rare)Liver injury, Depression, Low blood counts, Thyroid problems
Don't take ifAllergy to glatiramer or mannitolSevere depression; Uncontrolled epilepsy; Decompensated liver disease
AlcoholUsually no problem in moderation. No known interaction.Best to limit. Alcohol adds liver stress.
PregnancyUse with cautionConsidered relatively safe; discuss with your specialist.Use with cautionStop before planned pregnancy or review risk with specialist.
BreastfeedingGenerally considered safeNot absorbed orally by the baby.Generally considered safeLarge molecule; minimal transfer into milk.
In use since——
Brand namesUnited States: Copaxone, GlatopaUnited Kingdom: Copaxone, BrabioIndia: CopaxoneUnited States: Avonex, Rebif, BetaseronUnited Kingdom: Avonex, Rebif, BetaferonIndia: Avonex, Rebif, Betaferon
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL03AX13L03AB07

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker